메뉴 건너뛰기




Volumn 105, Issue 5, 2011, Pages 599-601

New tricks with old dogs: Personalised medicine and clinical trials

Author keywords

Bayesian trials; nomograms; Phase 2 trials

Indexed keywords

ACCURACY; ALGORITHM; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CLINICAL RESEARCH; DATA ANALYSIS; HIGH RISK PATIENT; HUMAN; METHODOLOGY; NOMOGRAM; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL (TOPIC); PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; REVIEW; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 80052004394     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.299     Document Type: Review
Times cited : (2)

References (8)
  • 1
    • 63449089608 scopus 로고    scopus 로고
    • Novel designs and end points for phase II clinical trials
    • Adjei AA, Christian M, Ivy P (2009) Novel designs and end points for phase II clinical trials. Clin Cancer Res 15: 1866-1872
    • (2009) Clin Cancer Res , vol.15 , pp. 1866-1872
    • Adjei, A.A.1    Christian, M.2    Ivy, P.3
  • 2
    • 33644861229 scopus 로고    scopus 로고
    • Bayesian clinical trials
    • Berry DA (2006) Bayesian clinical trials. Nat Rev Drug Discov 5: 27-36
    • (2006) Nat Rev Drug Discov , vol.5 , pp. 27-36
    • Berry, D.A.1
  • 5
    • 0032950295 scopus 로고    scopus 로고
    • Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
    • Kattan MW, Wheeler TM, Scardino PT (1999) Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17: 1499-1507 (Pubitemid 29220858)
    • (1999) Journal of Clinical Oncology , vol.17 , Issue.5 , pp. 1499-1507
    • Kattan, M.W.1    Wheeler, T.M.2    Scardino, P.T.3
  • 6
    • 33751045828 scopus 로고    scopus 로고
    • Defining high risk prostate cancer with risk groups and nomograms: Implications for designing clinical trials
    • DOI 10.1016/j.juro.2006.06.081, PII S0022534706014613
    • Roach III M, Weinberg V, Nash M, Sandler HM, McLaughlin PW, Kattan MW (2006) Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials. J Urol 76: S16-S20 (Pubitemid 44754980)
    • (2006) Journal of Urology , vol.176 , Issue.6 SUPPL.
    • Roach III, M.1    Weinberg, V.2    Nash, M.3    Sandler, H.M.4    McLaughlin, P.W.5    Kattan, M.W.6
  • 7
    • 51649109226 scopus 로고    scopus 로고
    • Comparison of nomograms with other methods for predicting outcomes in prostate cancer: A critical analysis of the literature
    • Shariat SF, Karakiewicz PI, Suardi N, Kattan MW (2008) Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res 14: 4400-4407
    • (2008) Clin Cancer Res , vol.14 , pp. 4400-4407
    • Shariat, S.F.1    Karakiewicz, P.I.2    Suardi, N.3    Kattan, M.W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.